13F-HR filed by Alphabet Inc.
Alphabet Inc. filed this 13F-HR for the quarter ended 2021-09-30, filed 2022-11-15, with 43 holding rows worth $4,215,098,000.
- Accession
- 0001567619-22-020226
- Filer
- CIK 1652044
- Filed
- 2022-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 52 entries on the cover page, a total value of $4,215,098,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,215,098,000 with VALUE read as thousands by filing date, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGV Management Company, L.L.C.028-22704
- included managerCapitalG Rise LLC028-22709
- included managerVerily Life Sciences LLC028-22703
- included managerGoogle LLC028-22705
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UIPATH INC | 90364P105 | CL A | 17,581,428 | $924,959,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 10,974,011 | $515,778,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 805,681 | $440,466,000 | thousands by filing date | |
| OSCAR HEALTH INC | 687793109 | CL A | 24,042,864 | $418,105,000 | thousands by filing date | |
| LYFT INC | 55087P104 | CL A COM | 6,138,154 | $328,944,000 | thousands by filing date | |
| ROBINHOOD MKTS INC | 770700102 | COM | 7,697,335 | $323,904,000 | thousands by filing date | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 5,680,785 | $239,956,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 4,100,475 | $142,984,000 | thousands by filing date | |
| DUOLINGO INC CL A COM | 26603R106 | Stock | 712,304 | $118,499,000 | thousands by filing date | |
| BENSON HILL INC | 082490103 | COM | 14,752,271 | $105,184,000 | thousands by filing date | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 5,865,125 | $86,804,000 | thousands by filing date | |
| DESKTOP METAL INC | 25058X105 | COM CL A | 11,048,730 | $79,219,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,812,500 | $63,338,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,641,497 | $51,756,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,464,015 | $32,618,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 1,438,232 | $30,145,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 321,604 | $27,983,000 | thousands by filing date | |
| BARINTHUS BIOTHERAPEUTICS PL | 91864C107 | ADS | 1,704,444 | $26,828,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 3,339,138 | $24,309,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 710,250 | $22,053,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 53,470 | $21,688,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 753,187 | $19,199,000 | thousands by filing date | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 915,705 | $18,909,000 | thousands by filing date | |
| CORTEXYME INC | 22053A107 | COM | 189,122 | $17,325,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 944,791 | $16,392,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 889,979 | $16,385,000 | thousands by filing date | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 1,636,258 | $12,616,000 | thousands by filing date | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 640,882 | $11,933,000 | thousands by filing date | |
| AMPLITUDE INC COM CL A | 03213A104 | Stock | 189,447 | $10,295,000 | thousands by filing date | |
| Tscan Therapeutics Inc | 89854M101 | COM | 1,077,080 | $8,983,000 | thousands by filing date | |
| EVELO BIOSCIENCES INC | 299734103 | COM | 1,060,495 | $7,466,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 646,622 | $7,236,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 255,452 | $7,206,000 | thousands by filing date | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 500,901 | $6,978,000 | thousands by filing date | |
| NEW RELIC INC | 64829B100 | COMMON STOCK | 91,132 | $6,541,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 215,965 | $6,140,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 698,262 | $4,574,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 175,866 | $4,013,000 | thousands by filing date | |
| Uber Technologies | 90353T100 | COM | 49,466 | $2,216,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 23,205 | $2,215,000 | thousands by filing date | |
| SQZ BIOTECHNOLOGIES CO | 78472W104 | COM | 103,929 | $1,499,000 | thousands by filing date | |
| TWILIO INC CL A | 90138F102 | Stock | 3,776 | $1,205,000 | thousands by filing date | |
| S&P Global,Inc. | 78409V104 | COM | 592 | $252,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-020226 | this filing | 2022-11-15 | acceptance time not in the bulk data set |